Mar 06, 2017 13:33 pm UTC| Business
WIXOM, Mich., March 06, 2017 -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for...
Mar 06, 2017 13:33 pm UTC| Business
WIXOM, Mich., March 06, 2017 -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for...
Mar 06, 2017 13:33 pm UTC| Business
WIXOM, Mich., March 06, 2017 -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for...
Mar 06, 2017 13:33 pm UTC| Business
Company to Host Webcast on Sunday, March 19, 2017 at 5:30 p.m. Eastern Time ANN ARBOR, Mich., March 06, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the lipid management company focused on developing and...
Mar 06, 2017 13:33 pm UTC| Business
Company to Host Webcast on Sunday, March 19, 2017 at 5:30 p.m. Eastern Time ANN ARBOR, Mich., March 06, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the lipid management company focused on developing and...
Mar 06, 2017 13:33 pm UTC| Business
Company to Host Webcast on Sunday, March 19, 2017 at 5:30 p.m. Eastern Time ANN ARBOR, Mich., March 06, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the lipid management company focused on developing and...
Luminar Media Group Inc., Provides Update on TherOZap™ Working Prototype
Mar 06, 2017 13:33 pm UTC| Business
Toronto, Ontario, March 06, 2017 -- Luminar Media Group, Inc., (Luminar, OTCMKTS: LRGR), reports that the development of the working prototype for the patent pending TherOZap™ is scheduled for completion prior to the...